Kirkbride Center

Kirkbride Center provides drug and alcohol treatment from its location at 111 North 49th Street in Philadelphia, Pennsylvania. It is a private provider.

Levels of care offered here include detox (medically supervised withdrawal), residential (inpatient) treatment, medication-assisted treatment (MAT), a federally certified opioid treatment program, and co-occurring (dual diagnosis) mental health treatment. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and motivational interviewing. For opioid use disorder, the program uses methadone, buprenorphine, and naltrexone. It also prescribes medication for alcohol use disorder.

Payment options include Medicaid, private health insurance, and cash or self-payment. Coverage depends on your specific plan, so verify benefits before admission.

The program accepts young adults, adults, and seniors. It offers specialized groups for pregnant/postpartum women, clients with co-occurring mental and substance use disorders, clients with co-occurring pain and substance use disorders, and clients with HIV or AIDS. Services are available in Spanish. Sign language services are available for deaf and hard-of-hearing clients.

Kirkbride Center is accredited by The Joint Commission and licensed or certified by the state substance use treatment agency, state mental health department, and state department of health.

Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.